A peptide sequence mimics the epitope on the multideterminant antigen (Tyr,Glu)-Ala-Lys that induces the dominant H10/V kappa 1+ primary antibody response.
C A Giorgetti, J L Press
Index: J. Immunol. 152(1) , 136-45, (1994)
Full Text: HTML
Abstract
The multideterminant Ag (Tyr,Glu)-Ala-Lys [(T,G)-A-L] elicits a heterogeneous secondary antibody response to different epitopes consisting of side-chain or backbone residues. However, the primary response is restricted and dominated by side-chain specific antibodies that also bind a random, linear copolymer of L-Glu and L-Tyr (GT+ antibodies), share TGB5 Id, and use the H10/V kappa 1 germ-line gene combination. We analyzed several defined sequence peptides to determine whether any might mimic the side-chain epitope(s) on (T,G)-A-L which induce the dominant Id+, H10/V kappa 1+ primary response. A carrier conjugate of the peptide TyrGluGluGluGluTyrTyrGluGluGluGluTyr (called TG4) was recognized by all the (T,G)-A-L-induced, GT+ hybridoma antibodies analyzed. In the splenic focus assay, the majority of primary and memory B cell clones induced by (T,G)-A-L produced antibodies that recognized the TG4 peptide. Mice immunized with TG4 conjugated to human gamma globulin (HGG) produced antibodies that bound (T,G)-A-L and were TGB5 Id+. Molecular analysis of Id+ primary hybridomas from TG4-HGG immunized mice showed that the antibodies used the H10 and V kappa 1 germ-line genes. Thus, the TG4 peptide can be bound by Id+, GT+ anti-(T,G)-A-L antibodies, and it induces Id+ antibodies that use the H10/V kappa 1 gene combination. By these criteria, the TG4 peptide mimics the side-chain epitope(s) on (T,G)-A-L that induces the dominant primary antibody response to that multideterminant Ag.
Related Compounds
Related Articles:
1996-04-01
[Immunol. Lett. 50(1-2) , 1-15, (1996)]
Dichotomy between the T and the B cell epitopes of the synthetic polypeptide (T,G)-A--L.
1994-10-01
[Eur. J. Immunol. 24(10) , 2497-505, (1994)]
A coronary artery fistula with saccular aneurysm mimicking a right atrial cystic mass.
2004-07-01
[Jpn. Heart J. 45(4) , 697-702, (2004)]
Dominant epitopes and synthetic peptides in myasthenia gravis.
1995-01-01
[Isr. J. Med. Sci. 31(1) , 10-2, (1995)]
Somatic mutation in the neonatal mouse.
1998-12-01
[J. Immunol. 161(11) , 6093-104, (1998)]